Asset Details
Do you wish to reserve the book?
The clinical importance of biochemical bone markers in patients with alcoholic and viral liver cirrhosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The clinical importance of biochemical bone markers in patients with alcoholic and viral liver cirrhosis
Do you wish to request the book?
The clinical importance of biochemical bone markers in patients with alcoholic and viral liver cirrhosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The clinical importance of biochemical bone markers in patients with alcoholic and viral liver cirrhosis
2014
Overview
Background: Metabolic bone disease in patients with chronic liver disease is called hepatic osteodystrophy and is primarily a sequel to osteopenia/osteoporosis, and rarely secondary to osteomalacia. The aim of this work was to define the influence of vitamin D3 and parathyroid hormone (PTH) in the pathogenesis of hepatic osteodystrophy, as well as the predictive significance of biochemical bone markers. Methods: This prospective study included 58 male patients with alcoholic (49) and viral (9) cirrhosis. The concentrations of serum vitamin D3, PTH, osteocalcin and ß-carboxy-terminal cross-linked telopeptide of type I collagen (ß-CTX) were determined. Bone density was measured by dual energy X-ray absorptiometry in the L1-L4 spinal segment and the femoral neck. Results: Lower bone mineral density (BMD) was measured in 41 patients (70.7%). There was no significant correlation between PTH and vitamin D3 values and T score in the femoral neck (p = 0.51; p = 0.063) and lumbar spine (p= 0.49; 0.064). Also, no significant correlation was found between the osteocalcin values in lumbar spine BMD (p= 0.944) and femoral neck (p= 0.161), or with ß-CTX values and BMD in the lumbar spine (p=0.347) and femoral neck (p=0.73). Statistically significant difference was confirmed between the stage A osteocalcin (p=0.000) and ß-CTX (p=0.008) values in relation to advanced stages B and C. Conclusions: PTH and vitamin D3 do not influence the development of hepatic osteodystrophy. In patients with cirrhosis, osteocalcin and ß-CTX are not valid indicators of decreased BMD, but their values correlate with the degree of liver insufficiency.
Publisher
Society of Medical Biochemists of Serbia, Belgrade
Subject
